Tokura Yoshiki, Mori Tomoko, Hino Ryosuke
Department of Dermatology, School of Medicine, University of Occupational and Environmental Health, Japan.
J UOEH. 2010 Dec 1;32(4):317-28. doi: 10.7888/juoeh.32.317.
T helper (Th) 17 cells have crucial functions in host defense, and dysregulated Th17 responses mediate a variety of autoimmune and inflammatory conditions. Th17 cells coexpress interleukin (IL)-22, and its receptor is expressed on epidermal keratinocytes. IL-17 and IL-22 cooperatively enhance some immunological responses. A close relationship between IL-17 and the cutaneous milieu has been suggested by a number of observations. IL-17 induces the production of certain cytokines, chemokines and antimicrobial peptides by keratinocytes, and its cooperation with IL-22 has been documented. Recent findings have suggested that Th17 cells profoundly participate in the pathogenesis of certain skin disorders, in particular, psoriasis. The concept of the subsets of T cells responsible for psoriasis has been modified in the order of Th1, T cytotoxic 1, and again Thl, and Thl7 cells. IL-22 is the strongest cytokine in the keratinocyte-proliferative ability. Since IL-22 is produced by Th17 cells, they are crucial for the proliferation of keratinocytes. Furthermore, IL-22 with the help of IL-17 can induce the critical events of psoriasis, including signal transducer and activator of transcription 3 (STAT3) activation, cytokine/chemokine (IL-8 etc.) production, and antimicrobial peptide elaboration. For maintaining Th17 cells, IL-23 is required and is released from tumor necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthetase (iNOS)-producing dendritic cells (TIP-DCs). TIP-DCs are activated via an autocrine mechanism by virtue of TNF-alpha. The above cytokine network in the pathogenesis of psoriasis has been proven by the therapeutic effectiveness of cytokine-blocking biologics. Antibodies against TNF-alpha or its soluble receptor have already been widely used in the treatment of psoriasis. The involvement of Th17 cells has also been shown in allergen-specific immune responses. The percentage of Th17 cells is increased in the peripheral blood of patients with atopic dermatitis (AD) and associated with the severity of AD. Drug eruption is another disease where Th17 cells are involved in the pathogenesis. The percentage of circulating Th17 cells are increased in drug-induced hypersensitivity syndrome, etc. Th17 cells and IL-22 are increased in patients with acute generalized exanthematous pustulosis. Since IL-17 and IL-22 cooperatively stimulate keratinocytes to produce IL-8, keratinocyte-derived IL-8 contributes to the accumulation ofneutrophils in the lesional epidermis of this drug eruption.
辅助性T(Th)17细胞在宿主防御中发挥着关键作用,而Th17反应失调会介导多种自身免疫性和炎症性疾病。Th17细胞共表达白细胞介素(IL)-22,其受体在表皮角质形成细胞上表达。IL-17和IL-22协同增强一些免疫反应。多项观察结果表明IL-17与皮肤环境之间存在密切关系。IL-17可诱导角质形成细胞产生某些细胞因子、趋化因子和抗菌肽,并且其与IL-22的协同作用已有文献记载。最近的研究发现表明,Th17细胞深刻参与某些皮肤疾病的发病机制,尤其是银屑病。负责银屑病的T细胞亚群概念已按Th1、细胞毒性T1的顺序,以及再次的Th1和Th17细胞进行了修正。IL-22是角质形成细胞增殖能力最强的细胞因子。由于IL-22由Th17细胞产生,它们对角质形成细胞的增殖至关重要。此外,IL-22在IL-17的帮助下可诱导银屑病的关键事件,包括信号转导和转录激活因子3(STAT3)的激活、细胞因子/趋化因子(如IL-8等)的产生以及抗菌肽的生成。为维持Th17细胞,需要IL-23,它由肿瘤坏死因子-α(TNF-α)和产生诱导型一氧化氮合酶(iNOS)的树突状细胞(TIP-DCs)释放。TIP-DCs通过TNF-α的自分泌机制被激活。银屑病发病机制中的上述细胞因子网络已通过细胞因子阻断生物制剂的治疗效果得到证实。抗TNF-α或其可溶性受体的抗体已广泛用于银屑病的治疗。Th17细胞也参与了变应原特异性免疫反应。特应性皮炎(AD)患者外周血中Th17细胞的百分比增加,且与AD的严重程度相关。药疹是另一种Th17细胞参与发病机制的疾病。在药物性超敏反应综合征等疾病中,循环Th17细胞的百分比增加。急性泛发性脓疱性银屑病患者的Th17细胞和IL-22增加。由于IL-17和IL-22协同刺激角质形成细胞产生IL-8,角质形成细胞衍生的IL-8有助于该药物性皮疹皮损表皮中中性粒细胞的聚集。